Thu, Mar 5, 2015, 3:07 AM EST - U.S. Markets open in 6 hrs 23 mins


% | $
Quotes you view appear here for quick access.

Vermillion, Inc. Message Board

  • marlin888 marlin888 Jun 9, 2013 9:35 PM Flag

    More people will realize value of VRML now

    that SGO has "endorsed" OVA1 last Friday June 7. This is a precursor to ACOG providing guideliens as both work together in this area. Pressure abound to payers. So here's how I see valuation:

    1 Total # of shares outstanding inc warrants 35MM
    2 From Quest VRML currently receives $110 per test. Given the latest developments with Quest (company changing the dynamic as per their recent 8k) and with better payer coverage company will receive ~$220 per test
    3 worldwide they will sell 500K tests per year
    4 For company valuation it is appropriate to take top line revenue - i.e. $635 per test.
    5 being conservative just taking $220 per test at 500k test per year equates to $110M annual revenue
    6 $110M x 8 multiple = $880M (revenue will be recurring annually essentially)
    7 $880M divided by 35MM shares equates to a SHARE PRICE OF $25.14 (twenty five dollars plus)
    8 today's share price is $2.76
    9 if we reduce multiple to conservative 5x value is $550m / 35MM shares which equates to a SP of $15.21 (fifteen dollars plus)
    Whichever one chooses it is irrelevant. With SGO (and therefore ACOG round the corner and better payer coverage) a stock price of $2.76 is Christmas come early. GLTA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.7899-0.0701(-3.77%)Mar 4 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.